PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 187 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $258,000 | -15.4% | 8,000 | -10.1% | 0.01% | -31.6% |
| Q3 2016 | $305,000 | -73.0% | 8,900 | -67.6% | 0.02% | -62.0% |
| Q3 2015 | $1,130,000 | -9.2% | 27,500 | +96.4% | 0.05% | -9.1% |
| Q1 2015 | $1,244,000 | -12.3% | 14,000 | -12.5% | 0.06% | +12.2% |
| Q4 2014 | $1,419,000 | +22.0% | 16,000 | +33.3% | 0.05% | +75.0% |
| Q3 2014 | $1,163,000 | -15.6% | 12,000 | -20.0% | 0.03% | -6.7% |
| Q2 2014 | $1,378,000 | +96.9% | 15,000 | +50.0% | 0.03% | +114.3% |
| Q1 2014 | $700,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |